Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Back

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Research|November 17, 2006
Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liverJeff J Subleski, Veronica L Hall, Timothy C Back, et al.
Plos One|March 20, 2012
Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilitiesTim Chan, Timothy C Back, Jeffrey J Subleski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumorsJimmy K Stauffer, Tahira Khan, Rosalba Salcedo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2Jon M Wigginton, Jong-Keuk Lee, Theresa A Wiltrout, et al.
Journal of the National Cancer Institute|February 2, 2006
Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastomaTahira Khan, Julie A Hixon, Jimmy K Stauffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforinNaoko Seki, Alan D Brooks, Clive R D Carter, et al.
Cancer Research|February 18, 2011
Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumorsJimmy K Stauffer, Anthony J Scarzello, Jesper B Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cellsRosalba Salcedo, Jimmy K Stauffer, Erin Lincoln, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
TCR-dependent and -independent activation underlie liver-specific regulation of NKT cellsJeff J Subleski, Veronica L Hall, Thomas B Wolfe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumorsTahira Khan, Jimmy K Stauffer, Rebecca Williams, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Research|November 17, 2006
Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liverJeff J Subleski, Veronica L Hall, Timothy C Back, et al.
Plos One|March 20, 2012
Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilitiesTim Chan, Timothy C Back, Jeffrey J Subleski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumorsJimmy K Stauffer, Tahira Khan, Rosalba Salcedo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2Jon M Wigginton, Jong-Keuk Lee, Theresa A Wiltrout, et al.
Journal of the National Cancer Institute|February 2, 2006
Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastomaTahira Khan, Julie A Hixon, Jimmy K Stauffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforinNaoko Seki, Alan D Brooks, Clive R D Carter, et al.
Cancer Research|February 18, 2011
Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumorsJimmy K Stauffer, Anthony J Scarzello, Jesper B Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cellsRosalba Salcedo, Jimmy K Stauffer, Erin Lincoln, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
TCR-dependent and -independent activation underlie liver-specific regulation of NKT cellsJeff J Subleski, Veronica L Hall, Thomas B Wolfe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumorsTahira Khan, Jimmy K Stauffer, Rebecca Williams, et al.
Pageof 2